Get all your news in one place.
100’s of premium titles.
One app.
Start reading
Benzinga
Benzinga
Business
Benzinga Insights

12 Health Care Stocks Moving In Monday's Intraday Session

 

Gainers

  • Karuna Therapeutics (NASDAQ:KRTX) shares increased by 63.5% to $229.46 during Monday's regular session. As of 13:30 EST, this security is trading at a volume of 3.3 million shares, making up 1079.7% of its average full-day volume over the last 100 days. The company's market cap stands at $6.8 billion. As per the press release, Q2 earnings came out today.
  • CinCor Pharma (NASDAQ:CINC) stock moved upwards by 52.83% to $35.84. CinCor Pharma's stock is trading at a volume of 1.8 million shares as of 13:30 EST. This is 1269.2% of its average full-day volume over the last 100 days. The company's market cap stands at $1.3 billion. The company's, Q2 earnings came out today.
  • Connect Biopharma Hldgs (NASDAQ:CNTB) shares increased by 42.42% to $1.88. Trading volume for Connect Biopharma Hldgs's stock is 5.1 million as of 13:30 EST. This is 1414.1% of its average full-day volume over the last 100 days. The company's market cap stands at $103.4 million.
  • Surgalign Holdings (NASDAQ:SRGA) shares moved upwards by 38.14% to $5.53. As of 13:30 EST, this security is trading at a volume of 724.7K shares, making up 133.8% of its average full-day volume over the last 100 days. The company's market cap stands at $36.6 million.
  • Aileron Therapeutics (NASDAQ:ALRN) stock moved upwards by 19.18% to $0.2. Trading volume for Aileron Therapeutics's stock is 4.2 million as of 13:30 EST. This is 711.6% of its average full-day volume over the last 100 days. The company's market cap stands at $18.6 million.
  • Aptinyx (NASDAQ:APTX) shares increased by 16.55% to $0.6. Trading volume for this security as of 13:30 EST is 475.2K, which is 148.8% of its average full-day volume over the last 100 days. The market value of their outstanding shares is at $40.6 million. The company's, Q2 earnings came out 2 days ago.

Losers

  • Reata Pharmaceuticals (NASDAQ:RETA) shares decreased by 33.2% to $23.85 during Monday's regular session. Reata Pharmaceuticals's stock is trading at a volume of 2.7 million shares as of 13:30 EST. This is 667.9% of its average full-day volume over the last 100 days. The market value of their outstanding shares is at $869.6 million. As per the news, the Q2 earnings report came out today.
  • Aethlon Medical (NASDAQ:AEMD) shares declined by 14.08% to $1.44. The current volume of 3.5 million shares is 88.6% of Aethlon Medical's average full-day volume over the last 100 days (last updated at 13:30 EST). The market value of their outstanding shares is at $23.8 million.
  • GH Research (NASDAQ:GHRS) stock decreased by 13.55% to $13.66. The market value of their outstanding shares is at $710.6 million.
  • Clovis Oncology (NASDAQ:CLVS) shares decreased by 13.26% to $1.44. Trading volume for this security as of 13:30 EST is 5.4 million, which is 41.1% of its average full-day volume over the last 100 days. The market value of their outstanding shares is at $207.1 million. As per the press release, Q2 earnings came out today.
  • G1 Therapeutics (NASDAQ:GTHX) stock fell 13.07% to $11.31. As of 13:30 EST, this security is trading at a volume of 2.5 million shares, making up 198.7% of its average full-day volume over the last 100 days. The market value of their outstanding shares is at $483.4 million. As per the news, the Q2 earnings report came out 3 days ago.
  • AlerisLife (NASDAQ:ALR) stock fell 12.87% to $1.49. The current volume of 212.5K shares is 196.0% of AlerisLife's average full-day volume over the last 100 days (last updated at 13:30 EST). The company's market cap stands at $48.6 million. As per the press release, Q2 earnings came out 3 days ago. See Also: www.benzinga.com/money/best-healthcare-stocks/

This article was generated by Benzinga's automated content engine and reviewed by an editor.

Sign up to read this article
Read news from 100’s of titles, curated specifically for you.
Already a member? Sign in here
Related Stories
Top stories on inkl right now
Our Picks
Fourteen days free
Download the app
One app. One membership.
100+ trusted global sources.